GlassScriptPhysician profile
Wendi I Kulin
NPI 1043411333
$806.17
in general payments reported to CMS, 2019-2025
15 companies · $27.79 in 2025
The $27.79 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $327 · 2021: $142 · 2023: $118 · 2025: $27.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $124.98 | 2020 | |
| Sunovion Pharmaceuticals INC. | $122.10 | 2020 | |
| Ambu INC. | $117.64 | 2023 | |
| Allergan, INC. | $86.70 | 2019-2021 | |
| Genzyme Corporation | $81.82 | 2021 | |
| Amgen INC. | $53.76 | 2019-2020 | |
| Ucb, INC. | $35.52 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $35.03 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $32.01 | 2019-2020 | |
| Promius Pharma LLC | $29.66 | 2019 | |
| Abbvie INC. | $27.79 | 2025 | |
| Lilly USA, LLC | $19.91 | 2020 | |
| Bausch Health US, LLC | $14.58 | 2019 | |
| Travere Therapeutics, INC. | $12.46 | 2019 | |
| Amneal Pharmaceuticals LLC | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendi Kulin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.